Navigation Links
Imprimis Announces Successful Results from its Pharmacokinetic Study for its Impracor Topical NSAID
Date:2/19/2013

h the FDA has mandated as a part of the clinical development of our Impracor topical NSAID program.  This study provides us with greater confidence in the performance of Impracor as we ready our team for our Phase 3 human clinical trials which are being planned to start in a matter of months."  

"We are happy with the successful outcome of this FDA recommended pharmacokinetic study comparing blood levels of ketoprofen under different 'real world' conditions," said Dr. Joachim Schupp , Imprimis Chief Medical Officer. "The results are consistent with previous pharmacokinetic findings with Impracor and provide guidance for safe dosing in our upcoming efficacy trials," Dr. Schupp added.

The study was conducted by Novum Pharmaceutical Research Services, based in Pittsburgh, PA, at the in-house clinical research facility in Las Vegas, NV. PPD Laboratories in Middleton, WI performed the analysis of the active drug in the blood samples.

About Imprimis Pharmaceuticals, Inc.

Imprimis Pharmaceuticals is a specialty pharmaceutical company focused on the commercial development of compounded drug formulations.  Through an exclusive strategic relationship with the largest compounding pharmacy organization in North America, Imprimis expects to use its proprietary Accudel drug delivery technology, coupled with licensed technologies, and proprietary formulations and market data, to identify pharmaceutical development opportunities where there is a significant unmet need for a new drug product.  Imprimis is also internally developing non-invasive, topically delivered products. Our innovative patented Accudel cream formulation technology is designed to enable highly targeted site-specific treatment. Impracor, our lead Phase 3 pain product candidate, utilizes the Accudel platform technology to d
'/>"/>

SOURCE Imprimis Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Stephen G. Austin, CPA Joins Imprimis Pharmaceuticals Board Of Directors
2. Dr. Gerald Yakatan Joins Imprimis Pharmaceuticals Science and Regulatory Advisory Board
3. Imprimis Pharmaceuticals Signs Agreement With DPT Labs For Clinical Supplies In Advance Of Planned Phase 3 Studies For Its Ketoprofen-Based Topical Anti-Inflammatory Drug
4. Imprimis Names Two Experts To Its Science And Regulatory Board
5. Imprimis to Begin New Study of Its Topical Analgesic Drug
6. Imprimis Pharmaceuticals Announces Pricing of Public Offering of 1,840,000 Shares of Common Stock
7. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
8. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
9. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
10. Misonix Announces New Distribution Agreement For Panama
11. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... WARRENVILLE, Ill. , Aug. 28, 2015 /PRNewswire/ ... Patterson Companies, Inc. (Nasdaq: PDCO ), is ... the previously announced acquisition of Patterson Medical by ... Medical will retain its name for a transition ... distributor of rehabilitation and sports medicine products.  With ...
(Date:8/28/2015)... The scientific team of a new biotech company ... academics in the field of aging Prof. Robert J. ... for model animals - 10 fold for nematodes) has recently ... primarily, around the stability and stress resistance of certain gene ... analysis of a model gene network links aging, stress resistance, ...
(Date:8/28/2015)... HERTFORDSHIRE, England and PITTSBURGH ... (NASDAQ: MYL ) today announced that its ... Company plc (NYSE: PRGO ; TASE) and ... Perrigo,s shareholders at an extraordinary general meeting of ... of two-thirds of the votes cast at the extraordinary general ...
Breaking Medicine Technology:Patterson Medical Positioned for Continued Growth as a Newly Independent Company 2Patterson Medical Positioned for Continued Growth as a Newly Independent Company 3Gero: Physics Meets Biology to Help Defeat Aging 2Gero: Physics Meets Biology to Help Defeat Aging 3Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 2Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 3Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 4Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 5Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 6Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 7Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 8Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 9
... Following a new report released today by the National ... WAISMANN METHOD® rapid detox treatment and Registered ... turn in their unused, unwanted, or expired prescription painkiller ... new government report based on data from 2009 to ...
... April 25, 2012 Varian Medical Systems (NYSE: ... announced the signing of a strategic global partnership ... services for treating cancer with image-guided radiotherapy and ... representation of products for imaging and treatment in ...
Cached Medicine Technology:WAISMANN METHOD® Director Encourages Public to Participate in National Take-Back Day 2WAISMANN METHOD® Director Encourages Public to Participate in National Take-Back Day 3Varian Medical Systems and Siemens Healthcare Announce Global Collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery 2Varian Medical Systems and Siemens Healthcare Announce Global Collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery 3Varian Medical Systems and Siemens Healthcare Announce Global Collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery 4Varian Medical Systems and Siemens Healthcare Announce Global Collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery 5Varian Medical Systems and Siemens Healthcare Announce Global Collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery 6Varian Medical Systems and Siemens Healthcare Announce Global Collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery 7
(Date:8/29/2015)... ... ... The popular television program VOICES IN AMERICA, hosted by legendary star of the ... entire short segment to the subject of diabetes. Diabetes is a debilitating health condition ... but recent advancements in medical science may prove to be a significant breakthrough that ...
(Date:8/28/2015)... ... 28, 2015 , ... Approximately 2,000 United Methodists are expected ... helping children, a thank you to the many creative and generous ways in ... United Methodist initiative to end malaria deaths. , The Columbus Zoo and Aquarium ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... Understanding the FDA’s Position and Best Practices for Compliance, **Presented by FDAnews ... This workshop, chaired by internationally renowned expert Fubin Wu, has been specifically ...
(Date:8/28/2015)... , ... August 28, 2015 , ... ... grams of high grade protein with zero fat, carbs, sugar, gluten, lactose or ... named a finalist for the 2015 SupplySide CPG Editor’s Choice Awards. , Five ...
(Date:8/28/2015)... Franklin, TN (PRWEB) , ... August 28, 2015 ... ... of recipients of the Veterans Award, honoring military veterans leading in business. ... 2015 honorees. , The inaugural Nashville Business Journal's 2015 Veterans Awards ...
Breaking Medicine News(10 mins):Health News:Saturday’s United Methodist Event at Columbus Zoo Celebrates Imagine No Malaria 2Health News:Saturday’s United Methodist Event at Columbus Zoo Celebrates Imagine No Malaria 3Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 2Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 3Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 4Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 5Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 2Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 3Health News:MyGenetx Board Member Receives Veterans Award 2
... allergy is not a reason to avoid getting the ... the American Academy of Allergy, Asthma & Immunology website, ... first be evaluated by an allergist or immunologist for ... vaccination. Matthew J. Greenhawt, M.D., M.B.A., clinical lecturer at ...
... -- Very young children are extraordinarily trusting of what adults ... contrary, finds a new study. In what may be ... that 3-year-olds placed more trust in information they are told ... study, an adult showed children a red and a yellow ...
... The National Cancer Institute has awarded a $4.37 ... Lombardi Comprehensive Cancer Center, to advance a recent scientific ... The grant, issued under the American Recovery and ... a new agent identified by Toretsky and his team ...
... of the prevalence of liver disease suggest that one‐third ... disease (NAFLD). NAFLD is now the most common cause ... a trend related to the obesity epidemic in this ... can lead to cirrhosis and all its complications. Two ...
... exploring the progression of colon polyps to colorectal cancer ... the clinical science presented at the 75th Annual Scientific ... Antonio today. The Progression to Colorectal Cancer in ... as sessile serrated adenomas (SSA) are found in approximately ...
... by Medicaid for administering influenza shots may raise vaccination ... of a study published online today in the journal ... team of researchers at the University of Rochester Medical ... seasons and contends that the number of poor children ...
Cached Medicine News:Health News:Egg allergy: Not a reason to avoid flu vaccine after all 2Health News:Egg allergy: Not a reason to avoid flu vaccine after all 3Health News:Young Kids Easily Trust What They're Told: Study 2Health News:$4.37 million NCI grant accelerates recent laboratory finding in Ewing's sarcoma 2Health News:$4.37 million NCI grant accelerates recent laboratory finding in Ewing's sarcoma 3Health News:Encouraging findings suggest new avenues for treating liver disease in overweight Americans 2Health News:Encouraging findings suggest new avenues for treating liver disease in overweight Americans 3Health News:Colonoscopy technique increases polyp detection in far reaches of right colon 2Health News:Medicaid reimbursement and childhood flu vaccination rates linked 2Health News:Medicaid reimbursement and childhood flu vaccination rates linked 3
... CCR Medical's Articulating Tip Laryngoscopes ... in the Industry. The articulating ... by providing an improved view ... and Fiber Optic styles. We ...
CCR Medical fiberoptic green system laryngoscope handles., ,OUTSTANDING PERFORMANCE, QUALITY, AND PRICING MAKE OUR FIBEROPTIC SELECTION MOST ECONOMICAL....
CCR Medical fiberoptic green system laryngoscope handles., ,OUTSTANDING PERFORMANCE, QUALITY, AND PRICING MAKE OUR FIBEROPTIC SELECTION MOST ECONOMICAL....
CCR Medical fiberoptic green system laryngoscope handles., ,OUTSTANDING PERFORMANCE, QUALITY, AND PRICING MAKE OUR FIBEROPTIC SELECTION MOST ECONOMICAL....
Medicine Products: